Matches in Wikidata for { <http://www.wikidata.org/entity/Q58024751> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q58024751 description "im Mai 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58024751 description "wetenschappelijk artikel" @default.
- Q58024751 description "наукова стаття, опублікована в травні 2011" @default.
- Q58024751 name "BRIM-2: An open-label, multicenter phase II study of vemurafenib in previously treated patients with BRAF V600E mutation-positive metastatic melanoma" @default.
- Q58024751 name "BRIM-2: An open-label, multicenter phase II study of vemurafenib in previously treated patients with BRAF V600E mutation-positive metastatic melanoma" @default.
- Q58024751 type Item @default.
- Q58024751 label "BRIM-2: An open-label, multicenter phase II study of vemurafenib in previously treated patients with BRAF V600E mutation-positive metastatic melanoma" @default.
- Q58024751 label "BRIM-2: An open-label, multicenter phase II study of vemurafenib in previously treated patients with BRAF V600E mutation-positive metastatic melanoma" @default.
- Q58024751 prefLabel "BRIM-2: An open-label, multicenter phase II study of vemurafenib in previously treated patients with BRAF V600E mutation-positive metastatic melanoma" @default.
- Q58024751 prefLabel "BRIM-2: An open-label, multicenter phase II study of vemurafenib in previously treated patients with BRAF V600E mutation-positive metastatic melanoma" @default.
- Q58024751 P1433 Q58024751-8523F1B5-64B0-4712-9CE6-00B16B468144 @default.
- Q58024751 P1476 Q58024751-AD0F9EA3-EF9D-4CBE-969F-5BCB22FA1AA0 @default.
- Q58024751 P2093 Q58024751-002380E1-40C0-4105-B382-A9384FF9703F @default.
- Q58024751 P2093 Q58024751-009892F7-86EB-45C9-A6A1-C5EF30681621 @default.
- Q58024751 P2093 Q58024751-112278F5-3FF4-479F-9BDA-2C068907D1F5 @default.
- Q58024751 P2093 Q58024751-16915EEF-05AE-497E-B2BE-7DC3E9C11188 @default.
- Q58024751 P2093 Q58024751-1F4D1410-043E-45EE-9DA6-87E3538627D6 @default.
- Q58024751 P2093 Q58024751-25117C37-9ACA-4584-9526-5BBEFD7CB026 @default.
- Q58024751 P2093 Q58024751-2E07CD1C-01F1-4C70-9E62-DF493D3F5F7E @default.
- Q58024751 P2093 Q58024751-3259C664-A728-4C11-8AA8-2A9313887117 @default.
- Q58024751 P2093 Q58024751-375ABC33-B41F-46C5-B969-7449445ED3C3 @default.
- Q58024751 P2093 Q58024751-3E0DED2B-59AB-4DB5-ACE5-E71F87819385 @default.
- Q58024751 P2093 Q58024751-48A5A82B-1A4C-48A6-8553-C29C2AEFF757 @default.
- Q58024751 P2093 Q58024751-533FC5CA-6019-47AA-A4CC-345D0E9C4D1D @default.
- Q58024751 P2093 Q58024751-547615F6-D023-48F1-9781-7EE8BC8FEC4D @default.
- Q58024751 P2093 Q58024751-555C1066-E9A5-4595-9D79-6B46EC1AF53B @default.
- Q58024751 P2093 Q58024751-59FE19AE-30A4-4EDA-A6E2-786D563619D3 @default.
- Q58024751 P2093 Q58024751-C3B28926-7E1B-49AD-92B2-EB83F589321A @default.
- Q58024751 P2093 Q58024751-C8B5346F-F292-49B1-BF9B-F5D493ADCCEF @default.
- Q58024751 P2093 Q58024751-F532D16B-FD93-4429-9ADE-7E05BE320BF3 @default.
- Q58024751 P2093 Q58024751-F9B0561A-44FB-4565-A99F-CB3244701A90 @default.
- Q58024751 P2093 Q58024751-FCE3BAB0-00A2-4F64-AA58-F179CAA1B8C1 @default.
- Q58024751 P304 Q58024751-7CBD89F4-A378-45DB-9FAC-469E755229DE @default.
- Q58024751 P31 Q58024751-A826C079-3679-4A38-B6B0-AA2EEFDB9D37 @default.
- Q58024751 P356 Q58024751-9DC54017-8A18-4DA9-89D8-3C52A3AF2FFB @default.
- Q58024751 P407 Q58024751-118B3A2C-DFD7-42B5-99B8-C419E28B81DF @default.
- Q58024751 P433 Q58024751-C9EB50F6-5517-4085-BB48-8A1AB41FBDAD @default.
- Q58024751 P478 Q58024751-34CC8FF5-4F28-4CC6-9D86-F50F3A674073 @default.
- Q58024751 P577 Q58024751-7EAB66ED-D70A-4F8F-9ED2-A50799F39E7B @default.
- Q58024751 P921 Q58024751-F0D873A1-3ECD-48DD-AF8F-C8F5F9A4D355 @default.
- Q58024751 P356 JCO.2011.29.15_SUPPL.8509 @default.
- Q58024751 P1433 Q400292 @default.
- Q58024751 P1476 "BRIM-2: An open-label, multicenter phase II study of vemurafenib in previously treated patients with BRAF V600E mutation-positive metastatic melanoma" @default.
- Q58024751 P2093 "A. C. Pavlick" @default.
- Q58024751 P2093 "A. K. Joe" @default.
- Q58024751 P2093 "A. Ribas" @default.
- Q58024751 P2093 "B. Chmielowski" @default.
- Q58024751 P2093 "D. P. Lawrence" @default.
- Q58024751 P2093 "G. A. McArthur" @default.
- Q58024751 P2093 "I. Puzanov" @default.
- Q58024751 P2093 "J. A. Sosman" @default.
- Q58024751 P2093 "J. Li" @default.
- Q58024751 P2093 "J. S. Weber" @default.
- Q58024751 P2093 "K. B. Kim" @default.
- Q58024751 P2093 "K. B. Nolop" @default.
- Q58024751 P2093 "K. T. Flaherty" @default.
- Q58024751 P2093 "L. M. Schuchter" @default.
- Q58024751 P2093 "P. Hersey" @default.
- Q58024751 P2093 "R. F. Kefford" @default.
- Q58024751 P2093 "R. Gonzalez" @default.
- Q58024751 P2093 "R. J. Lee" @default.
- Q58024751 P2093 "S. J. Moschos" @default.
- Q58024751 P2093 "T. E. Hutson" @default.
- Q58024751 P304 "8509-8509" @default.
- Q58024751 P31 Q13442814 @default.
- Q58024751 P356 "10.1200/JCO.2011.29.15_SUPPL.8509" @default.
- Q58024751 P407 Q1860 @default.
- Q58024751 P433 "15_suppl" @default.
- Q58024751 P478 "29" @default.
- Q58024751 P577 "2011-05-20T00:00:00Z" @default.
- Q58024751 P921 Q18975855 @default.